Print

Abbott Laboratories (ABT) to Cut 3,000 Jobs Following Solvay Pharmaceuticals, Inc. Deal  
9/21/2010 8:10:17 AM

NEW YORK, Sept 21 (Reuters) - Abbott Laboratories Inc (ABT.N) plans to cut 3,000 jobs, or about 3 percent of its workforce, following its purchase of Solvay's (SOLB.BR) pharmaceuticals business.
//-->